For the quarter ended June 2024, Corteva, Inc. (CTVA Quick QuoteCTVA - Free Report) reported revenue of $6.11 billion, up 1.1% over the same period last year. EPS came in at $1.83, compared to $1.60 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $6.1 billion, representing a surprise of +0.14%. The company delivered an EPS surprise of +5.17%, with the consensus EPS estimate being $1.74.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Corteva, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Seed

  : $4.33 billion versus the three-analyst average estimate of $4.36 billion. The reported number represents a year-over-year change of +1.6%.

• Revenue- Crop Protection

  : $1.78 billion versus $1.79 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a 0% change.

• Revenue- Crop Protection- Other

  : $170 million versus the two-analyst average estimate of $174.47 million. The reported number represents a year-over-year change of -19.8%.

• Revenue- Seed- Other

  : $145 million compared to the $171.61 million average estimate based on two analysts. The reported number represents a change of +2.1% year over year.

• Revenue- Crop Protection- Herbicides

  : $946 million compared to the $994.99 million average estimate based on two analysts. The reported number represents a change of -4.1% year over year.

• Revenue- Crop Protection- Insecticides

  : $415 million versus the two-analyst average estimate of $424.78 million. The reported number represents a year-over-year change of +25.4%.

• Revenue- Crop Protection- Fungicides

  : $250 million compared to the $301.89 million average estimate based on two analysts. The reported number represents a change of -0.8% year over year.

• Revenue- Seed- Soybean

  : $1.32 billion versus $1.32 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +4.9% change.

• Revenue- Seed- Corn

  : $2.68 billion versus $2.59 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.4% change.

• Revenue- Seed- Other oilseeds

  : $186 million compared to the $225.09 million average estimate based on two analysts. The reported number represents a change of -4.1% year over year.

• Operating EBITDA- Seed

  : $1.70 billion compared to the $1.54 billion average estimate based on three analysts.

• Operating EBITDA- Corporate

  : -$36 million compared to the -$28.88 million average estimate based on three analysts.

View all Key Company Metrics for Corteva, Inc. here>>>

Shares of Corteva, Inc. have returned +5.2% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.